Calcineurin inhibitors, such as cyclosporine and tacrolimus (FK506) are broadly used in organ transplantations as immune suppressants. As the calcineurin/NFAT signaling pathway has been identified as critical pathway in the interleukin-2 (IL-2) production of T cells, inhibition of T-cell derived IL-2 has been considered the major mechanism of calcineurin inhibitors. However, there is increasing evidence that NFAT transcription factor is involved in multiple functions of dendritic cells and innate immune cells as well. NFAT expression is not restricted to T cells, and IL-2 can be produced in dendritic cells and macrophages through the calcineurin/NFAT pathway. Furthermore, it has been discovered that NFAT regulates expressions of several inflammatory mediators, including TNF-α and cyclooxygenase-2 in innate immune cells. Therefore, calcineurin inhibitors may have much broader effects in the transplant recipients than previously being considered. In this review, we reviewed recently discovered roles of NFAT pathway in dendritic cells and innate immune cells, and discussed positive and negative implications of calcineurin inhibitors' broader effects with a focus on islet xenotransplantation.
I. INTRODUCTION
Nuclear factor of activated T cells (NFAT) was originally identified in nuclear extracts of activated T cells as a DNA-binding factor which binds to the interleukin-2 (Il2) promoter (1). Later, it was shown that inhibition of NFAT is the primary mechanism of calcineurin inhibitors, including cyclosporine and FK506 (tacrolimus) (2, 3) . These potent immune suppressants revolutionized allogeneic organ transplantations, dramatically raising 5-year survival rates of allografts since the introduction of cyclosporine into clinical practice. Before recent discoveries, inhibition of NFATmediated IL-2 production in T cells had been considered the principal mechanism of action for the calcineurin inhibitors. However, despite its name, the expression of NFAT is not limited to T cells. It has been shown that NFAT is expressed by almost every cell type, including other cells of the immune system (4~8). Due to the recent discoveries, it is now clear that NFAT has important functions in cells 1 of the innate immune system (9) .
During the past two decades, significant progress has been made in the field of xenotransplantation. Especially, successful long-term survival results have been achieved in pre-clinical pig-to-non-human primate islet xenotransplantation (10) . Due to successful results in pre-clinical studies, it seems that clinical trials of islet xenotransplantation may take place within a few years (11, 12) . Therefore, transplantation of islets is likely to be the first introduction of xenotransplantation into clinic, thereby providing an ultimate solution to the problem of donor organ supply for curing Type I diabetes.
Though the acute rejection of xenogeneic islets is primarily a T cell-dependent process (13) , regulations of the innate immunity may bring beneficial effects for achieving long-term graft acceptance in islet xenotransplantation. In this review we overview the actions of calcineurin/NFAT inhibitors in T cells and innate immune cells, and discuss its implications in islet xenotransplantation.
II. The Classical Calcineurin/NFAT Signaling Pathway in T Cells
The classical calcineurin/NFAT signaling pathway in T cells and its inhibition by calcineurin inhibitors can be summarized as follows (Fig. 1 kine genes (7, 8) .
In fact, the mechanism of NFAT activation was discovered indirectly by mechanism studies of the calcineurin inhibi- 
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Clinical islet transplantation is performed to the liver through the portal vein. In this situation, the infused islets 
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It is well-known that NFAT is involved in the devel- 
VI. Effects on Beta-cell Function
Islet transplantation aims to supply insulin-producing β-cells and normalize blood glucose levels in Type 1 diabetes patients. To achieve this goal, transplanted β-cells have to maintain viability, and produce and secrete insulin. ished insulin production and secretion (81, 92) , and impaired insulin sensitivity (93, 94) . Considering the reversibility after withdrawal of the drug (95), impaired insulin secretion and insulin resistance seems to be the major mechanisms. outcomes (27) . Although it is complicated, thorough research and understanding of the roles of NFAT in diverse immune cells is required. Through the improvement in the understanding on the roles of calcineurin/NFAT, calcineurin inhibitors can be utilized more effectively and safely in the transplant recipients.
VII. CONCLUSION
